Review ArticleClinical Review

Hepatitis C for Primary Care Physicians

Miranda M. Huffman and Anne L. Mounsey
The Journal of the American Board of Family Medicine March 2014, 27 (2) 284-291; DOI: https://doi.org/10.3122/jabfm.2014.02.130165

References

  1. 1.↵
    1. Lauer GM,
    2. Walker BD
    . Hepatitis C virus infection. N Engl J Med 2001;345:41–52.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    1. Ghany MG,
    2. Strader DB,
    3. Thomas DL,
    4. Seeff LB
    ; American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009;49:1335–74.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Armstrong GL,
    2. Wasley A,
    3. Simard EP,
    4. McQuillan GM,
    5. Kuhnert WL,
    6. Alter MJ
    . The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006;144:705–14.
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    1. Smith BD,
    2. Morgan RL,
    3. Beckett GA,
    4. et al
    . Centers for Disease Control and Prevention. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945–1965. MMWR Recomm Rep 2012;61(RR-4):1–32.
    OpenUrlPubMed
  5. 5.↵
    Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention. MMWR Recomm Rep 1998;47(RR-19):1–39.
    OpenUrlPubMed
  6. 6.↵
    1. Moyer VA
    ; U.S. Preventive Services Task Force. Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2013;159:349–57.
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    1. Chou R,
    2. Cottrell EB,
    3. Wasson N,
    4. et al
    . Screening for hepatitis C virus infection in adults. Comparative effectiveness reviews, no. 69 [Internet]. Rockville (MD): Agency for Healthcare Research and Quality; November 2012. Available from: http://www.ncbi.nlm.nih.gov/books/NBK115428/. Accessed January 22, 2014.
  8. 8.↵
    1. Kamal SM
    . Acute hepatitis C: a systematic review. Am J Gastroenterol 2008;103:1283–97.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    1. Thomas D,
    2. Seeff L
    . Natural history of hepatitis C. Clin Liver Dis 2005;9:383–98.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Agnello V,
    2. De Rosa FG
    . Extrahepatic disease manifestations of HCV infection: some current issues. J Hepatol 2004;40:341–52.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Zignego AL,
    2. Craxì A
    . Extrahepatic manifestations of hepatitis C virus infection. Clin Liver Dis 2008;12:611–36.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.
    1. Kroenke K,
    2. Spitzer RL,
    3. Williams JB
    . The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16:606–13.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.
    1. Bush K,
    2. Kivlahan DR,
    3. McDonell MB,
    4. Fihn SD,
    5. Bradley KA
    . The AUDIT Alcohol Consumption Questionnaire (AUDIT-C): an effective brief screening test for problem drinking. Arch Intern Med 1998;158:1789–95.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    1. Fontana RJ,
    2. Lok AS
    . Noninvasive monitoring of patients with chronic hepatitis C. Hepatology 2002;36(5 Suppl 1):S57–64.
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    1. Backus LI,
    2. Boothroyd DB,
    3. Phillips BR,
    4. Belperio P,
    5. Halloran J,
    6. Mole LA
    . A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C. Clin Gastroenterol Hepatol 2011;9:509–16.e1.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Ghany MG,
    2. Nelson DR,
    3. Strader DB,
    4. Thomas DL,
    5. Seeff LB
    . An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology 2011;54:1433–44.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. Liang TJ,
    2. Ghany MG
    . Current and future therapies for hepatitis C virus infection. N Engl J Med 2013;368:1907–17.
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    1. Lee LY,
    2. Tong CY,
    3. Wong T,
    4. Wilkinson M
    . New therapies for chronic hepatitis C infection: a systematic review of evidence from clinical trials. Int J Clin Pract 2012;66:342–55.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Arora S,
    2. Thornton K,
    3. Murata G,
    4. et al
    . Outcomes of treatment for hepatitis C virus infection by primary care providers. N Engl J Med 2011;364:2199–207.
    OpenUrlCrossRefPubMedWeb of Science
  20. 20.↵
    1. Khatri K,
    2. Haddad M,
    3. Anderson D
    . Project ECHO: replicating a novel model to enhance access to hepatitis C care in a community health center. J Health Care Poor Underserved 2013;24:850–8.
    OpenUrlPubMed
  21. 21.↵
    1. Shim M,
    2. Khaykis I,
    3. Park J,
    4. Bini EJ
    . Susceptibility to hepatitis A in patients with chronic liver disease due to hepatitis C virus infection: missed opportunities for vaccination. Hepatology 2005;42:688–95.
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    1. Tsai JF,
    2. Jeng JE,
    3. Ho MS,
    4. Chang WY,
    5. Lin ZY,
    6. Tsai JH
    . Independent and additive effect modification of hepatitis C and B viruses infection on the development of chronic hepatitis. J Hepatol 1996;24:271–6.
    OpenUrlCrossRefPubMedWeb of Science
  23. 23.↵
    Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2012;61:816–9.
    OpenUrlPubMed
  24. 24.↵
    1. Wiley TE,
    2. McCarthy M,
    3. Breidi L,
    4. McCarthy M,
    5. Layden TJ
    . Impact of alcohol on the histological and clinical progression of hepatitis C infection. Hepatology 1998;28:805–9.
    OpenUrlCrossRefPubMedWeb of Science
  25. 25.↵
    1. Corrao G,
    2. Aricò S
    . Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis. Hepatology 1998;27:914–9.
    OpenUrlCrossRefPubMedWeb of Science
  26. 26.↵
    1. Westin J,
    2. Lagging LM,
    3. Spak F,
    4. et al
    . Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection. J Viral Hepat 2002;9:235–41.
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    1. Ortiz V,
    2. Berenguer M,
    3. Rayon JM,
    4. Carrasco D,
    5. Berenguer J
    . Contribution of obesity to hepatitis C-related fibrosis progression. Am J Gastroenterol 2002;9:2408–14.
    OpenUrl
  28. 28.↵
    1. Terrault NA,
    2. Dodge JL,
    3. Murphy EL,
    4. et al
    . Sexual transmission of HCV among monogamous heterosexual couples: the HCV Partners Study. Hepatology 2013;57:881–9.
    OpenUrlCrossRefPubMedWeb of Science
  29. 29.↵
    1. Tohme RA,
    2. Holmberg SD
    . Is sexual contact a major mode of hepatitis C virus transmission? Hepatology 2010;52:1497–505.
    OpenUrlCrossRefPubMedWeb of Science
  30. 30.↵
    1. Onofrei MD,
    2. Butler KL,
    3. Fuke DC,
    4. Miller HB
    . Safety of statin therapy in patients with preexisting liver disease. Pharmacotherapy 2008;28:522–9.
    OpenUrlCrossRefPubMed
  31. 31.↵
    1. Bader T,
    2. Fazili J,
    3. Madhoun M,
    4. et al
    . Fluvastatin inhibits hepatitis C replication in humans. Am J Gastroenterol 2008;103:1383–9.
    OpenUrlCrossRefPubMedWeb of Science
  32. 32.↵
    1. Rao GA,
    2. Pandya PK
    . Statin therapy improves sustained virologic response among diabetic patients with chronic hepatitis C. Gastroenterology 2011;140:144–52.
    OpenUrlCrossRefPubMedWeb of Science
  33. 33.↵
    1. Tzefos M,
    2. Olin JL
    . 3-Hydroxyl-3-methylglutaryl coenzyme A reductase inhibitor use in chronic liver disease: a therapeutic controversy. J Clin Lipidol 2011;5:450–9.
    OpenUrlPubMed
  34. 34.↵
    1. Calderon RM,
    2. Cubeddu LX,
    3. Goldberg RB,
    4. Schiff ER
    . Statins in the treatment of dyslipidemia in the presence of elevated liver aminotransferase levels: a therapeutic dilemma. Mayo Clin Proc 2010;85:349–56.
    OpenUrlCrossRefPubMedWeb of Science
  35. 35.↵
    1. Benson GD,
    2. Koff RS,
    3. Tolman KG
    . The therapeutic use of acetaminophen in patients with liver disease. Am J Ther 2005;12:133–41.
    OpenUrlCrossRefPubMed
  36. 36.↵
    1. Mehta G,
    2. Rothstein KD
    . Health maintenance issues in cirrhosis. Med Clin North Am 2009;93:901–15, viii–ix.
    OpenUrlPubMed
  37. 37.↵
    1. Castro-Fernández M,
    2. Sánchez-Muñoz D,
    3. Galán-Jurado MV,
    4. et al
    . Influence of nonsteroidal antiinflammatory drugs in gastrointestinal bleeding due to gastroduodenal ulcers or erosions in patients with liver cirrhosis. Gastroenterol Hepatol 2006;29:11–4.
    OpenUrlPubMed
  38. 38.↵
    1. Laffi G,
    2. La Villa G,
    3. Pinzani M,
    4. Marra F,
    5. Gentilini P
    . Arachidonic acid derivatives and renal function in liver cirrhosis. Semin Nephrol 1997;17:530–48.
    OpenUrlPubMed
  39. 39.↵
    1. Hirschfield GM,
    2. Kumagi T,
    3. Heathcote EJ
    . Preventative hepatology: minimising symptoms and optimising care. Liver Int 2008;28:922–34.
    OpenUrlPubMed
  40. 40.↵
    1. Asnis GM,
    2. De La Garza R 2nd.
    . Interferon-induced depression in chronic hepatitis C: a review of its prevalence, risk factors, biology, and treatment approaches. J Clin Gastroenterol 2006;40:322–35.
    OpenUrlCrossRefPubMed
  41. 41.↵
    1. Morasco BJ,
    2. Rifai MA,
    3. Loftis JM,
    4. et al
    . A randomized trial of paroxetine to prevent interferon-alpha-induced depression in patients with hepatitis C. J Affect Disord 2007;103:83–90.
    OpenUrlCrossRefPubMed
  42. 42.↵
    1. Bruix J,
    2. Sherman M
    . Management of hepatocellular carcinoma. Hepatology 2005;42:1208–36.
    OpenUrlCrossRefPubMedWeb of Science
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Keywords